Literature DB >> 20100790

The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's disease.

Marcelo L Cunha, Jairo Wagner, Akemi Osawa, Morton Scheinberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100790     DOI: 10.1093/rheumatology/kep441

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

1.  Comment on: is Still's disease still one disease? A case of adult-onset Still's disease showing accumulation in the carotids and the large vessels of the legs on positron emission tomography: CT images.

Authors:  Veli Yazisiz; Hatice Yazisiz
Journal:  Rheumatol Int       Date:  2011-12-30       Impact factor: 2.631

Review 2.  Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging.

Authors:  Ali Gholamrezanezhad; Kyle Basques; Ali Batouli; George Matcuk; Abass Alavi; Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2018-06       Impact factor: 3.959

Review 3.  Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.

Authors:  Rene Thonhofer; Manuela Hiller; Horst Just; Markus Trummer; Cornelia Siegel; Christian Dejaco
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 3.580

4.  Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.

Authors:  Atsushi Ogata; Toshio Tanaka
Journal:  Int J Rheumatol       Date:  2012-01-18

5.  The role of 18F-fluorodeoxyglucose positron emission tomography in the assessment of disease activity of adult-onset Still's disease.

Authors:  Young-Sil An; Chang-Hee Suh; Ju-Yang Jung; Hundo Cho; Hyoun-Ah Kim
Journal:  Korean J Intern Med       Date:  2016-12-07       Impact factor: 2.884

6.  Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.

Authors:  Attila Hamar; Zsolt Hascsi; Anita Pusztai; Monika Czókolyová; Edit Végh; Zsófia Pethő; Katalin Gulyás; Boglárka Soós; György Kerekes; Éva Szekanecz; Katalin Hodosi; Sándor Szántó; Gabriella Szűcs; Tamás Seres; Zoltán Szekanecz; Szilvia Szamosi
Journal:  RMD Open       Date:  2021-11

Review 7.  Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.

Authors:  Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580

Review 8.  Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence.

Authors:  Hubert de Boysson; Jérome Février; Amélie Nicolle; Christophe Auzary; Loïk Geffray
Journal:  Clin Rheumatol       Date:  2012-10-30       Impact factor: 3.650

9.  18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Magnetic Resonance for Diagnosing Adult-Onset Still's Disease.

Authors:  Sara Bindoli; Paola Galozzi; Fabio Magnani; Laura Rubin; Cristina Campi; Andrea Doria; Diego Cecchin; Paolo Sfriso
Journal:  Front Med (Lausanne)       Date:  2020-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.